Carnyx targets 2027 IND filing for oral sleep candidate CNYX-005
Carnyx Therapeutics plans a fall 2027 IND for CNYX-005, an oral small molecule that added 1.5 to 2 hours of mostly NREM sleep in aged rats.
Carnyx Therapeutics plans a fall 2027 IND for CNYX-005, an oral small molecule that added 1.5 to 2 hours of mostly NREM sleep in aged rats.